Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nihon Koden Acquires U.S. Software Developer Neurotronics

This article was originally published in PharmAsia News

Executive Summary

Nihon Koden announced Dec. 26 the company will acquire 100 percent of shares of U.S. software developing company Neurotronics by Dec. 31. Nihon Koden's move is to further strengthen its sleep respiratory business, which the company hopes to reach ¥1 billion in sales by March 2009 and ¥2 billion by March 2011. The company will utilize sleep brain wave analysis technology developed by Neurotronics and develop products to treat sleep apnea syndrome. Based in Gainesville, Florida, Neurotronics has 18 employees. Nihon Koden estimates that Polysomnography all-night sleep polygraph testing that uses brain wave analysis software to diagnose SAS will spread rapidly in the future. (Click here for more - Japanese language

You may also be interested in...



Vaccine Experts Inject Realism Into US Gov't's COVID-19 Timeline

The Trump administration says a COVID-19 vaccine could be available in as little as 12 months, but most experts think that is overpromising unless safety or efficacy standards are sacrificed. Many are urging pivotal studies that look at clinical outcomes, not surrogates, for US FDA approval. 

Trump Pushes Back On OIG Report That Hospitals Want Feds To Better Police Resources, Relax Regs

When asked about an inspector general report that found hospitals are struggling with tests and resources, and are looking to the federal government to help facilitate more efficient distribution of medical devices to fight the COVID-19 crisis, President Trump attacked the report as a political hit from an Obama holdover.

Execs On The Move: Promotions Are In The Spotlight At Terumo And MiMedx Group

Japanese medical device manufacturer Terumo Corp. promoted senior management execs; MiMedx Group, developer of human placental tissue allografts, raised exec to CFO; and more.

UsernamePublicRestriction

Register

SC069980

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel